Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 121, Issue 9, Pages 786-795
Publisher
Springer Science and Business Media LLC
Online
2019-10-07
DOI
10.1038/s41416-019-0595-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment
- (2018) Jingying Zhang et al. HEPATOLOGY
- Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status
- (2017) Sylvie Giacchetti et al. EUROPEAN JOURNAL OF CANCER
- Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)
- (2017) Martin J. Edelman et al. JOURNAL OF CLINICAL ONCOLOGY
- Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial
- (2017) Malcolm D. Mason et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Pancreatic Expression of Immunoglobulin G in Human Pancreatic Cancer and Associated Diabetes
- (2015) Xia Wan et al. PANCREAS
- Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-analysis of 11 Randomized Clinical Trials
- (2014) Jian Chen et al. CLINICAL THERAPEUTICS
- Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis
- (2014) Ole Helm et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis
- (2014) Long-Yun Ye et al. PANCREATOLOGY
- Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages
- (2014) Lisa T. C. Vogelpoel et al. Nature Communications
- Recent progress in pancreatic cancer
- (2013) Christopher L. Wolfgang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
- (2013) Qi Zhang et al. CARCINOGENESIS
- M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
- (2013) Chao-Ying Liu et al. LABORATORY INVESTIGATION
- Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1β in human pancreatic cancer cells: Role of JNK
- (2012) Gaurav Verma et al. CANCER LETTERS
- IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
- (2012) Yijing Li et al. Molecular Cancer
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- New biomarkers and targets in pancreatic cancer and their application to treatment
- (2012) Eithne Costello et al. Nature Reviews Gastroenterology & Hepatology
- Overcoming drug resistance in pancreatic cancer
- (2011) Jiang Long et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
- (2010) N Hiraoka et al. BRITISH JOURNAL OF CANCER
- Inflammation, but not hypoxia, mediated HIF-1α activation depends on COX-2
- (2010) Ioannis Stasinopoulos et al. CANCER BIOLOGY & THERAPY
- Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
- (2010) Allan Lipton et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
- (2009) F. Colotta et al. CARCINOGENESIS
- Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
- (2008) Tomislav Dragovich et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
- (2008) Bing-Hua Jiang et al. DRUG RESISTANCE UPDATES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started